Aditx Therapeutics

Aditxt, Inc. (Nasdaq: ADTX) is a biotechnology innovation company dedicated to improving immune system health. It is developing technologies specifically aimed at enhancing immune system health through immune monitoring and reprogramming. Aditxt's immune monitoring technology is designed to provide a personalized and comprehensive profile of the immune system. Aditxt's immune reprogramming technology, currently in the preclinical stage, aims to retrain the immune system to induce tolerance, with the goal of addressing transplant organ rejection, autoimmune diseases, and allergies.